Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | FHA-11 KRAS G12V-TCR |
| Trade Name | |
| Synonyms | FHA-11KRAS G12V-TCR |
| Drug Descriptions |
FHA-11 KRAS G12V-TCR comprises autologous T-cells expressing an HLA-A*11-restricted T-cell receptor (TCR) targeting KRAS G12V, which potentially induces T-cell activation and tumor cell killing (Apr 2024). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| FHA-11 KRAS G12V-TCR | FHA-11 KRAS G12V-TCR | 0 | 1 |